Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute myocardial infarction

Lancet

Volumn 354, Issue 9172, 1999, Pages 9-12

  Torp Pedersen, Christian ^a   Køber, Lars ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TRANDOLAPRIL;

ACUTE HEART INFARCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SURVIVAL;

EID: 0033519923     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)09374-X     Document Type: Article

References (14)

1. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 342:1993;821-828.
2. Pfeffer M.A., Braunwald E., Moyé L.A.et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Englargement Trial. N Engl J Med. 327:1992;69-77.
3. Køber L., Torp-Pedersen C., Carlsen J.E.et al. A clinical trial of the angiotensin converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 333:1995;1670-1676.
4. Køber L., Torp-Pedersen C. Clincal characteristics and mortality of patients screened for entry into the Trandolapril Cardiac Evaluation (TRACE) Study. Am J Cardiol. 76:1995;1-5.
5. Køber L., Torp-Pedersen C., Carlsen J., Videbaek R., Egeblad H. An echocardiographic method for selecting high risk pateints shortly after acute myocardial infarction, for inclusion in multicentre studies as used in the TRACE study. Eur Heart J. 15:1994;1616-1620.
6. Berning J., Rokkedal-Nielsen J., Launbjerg J., Fogh J., Mickley H., Andersen P.E. Rapid estimation of left ventricular ejection fraction in acute myocardial infarction by echocardiographic wall motion analysis. Cardiology. 80:1992;257-260.
7. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med. 327:1992;685-691.
8. Effect of enalapril on survival in pateints with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:1991;293-302.
9. Torp-Pedersen C., Køber L., Carlsen J. Angiotensin-converting enzyme inhibition after myocardial infarction: the Trandolapril Cardiac Evaluation Study. Am Heart J. 132(suppl 2):1996;235-243.
10. Gustafsson F., Torp-Pedersen C., Køber L., Hildebrandt P. Effect of angiotensin converting enzyme inhibition after acute myocardial infarction in patients with arterial hypertension: TRACE Study Group. Hypertens. 15:1997;793-798.
11. Stevenson R., Ranjadayalan K., Wilkinson P., Roberts R., Timmis A. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis. BMJ. 307:1993;349-353.
12. Emanuelsson H., Karlson B.W., Herlitz J. Characteristics and prognosis of patients with acute myocardial infarction in relation to occurrence of congestive heart failure. Eur Heart J. 15:1994;761-768.
13. McGovern P.G., Pankow J.S., Shahar E.et al. Recent trends in acute coronary heart disease. Mortality, morbidity, medical care, and risk factors. N Engl J Med. 334:1996;884-890.
14. Hall A.S., Murray G.D., Ball S.G. Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study. Lancet. 349:1997;1493-1497.